The Critically Ill Infant with Congenital Heart Disease

Ashley M Strobel1, Le N Lu2

  • 1Department of Emergency Medicine, University of Maryland Medical Center, 110 South Paca Street, 6th Floor, Suite 200, Baltimore, MD 21201, USA; Department of Pediatrics, University of Maryland Medical Center, 22 South Greene Street, North Hospital, 5th floor, Baltimore, MD 21201, USA.

Insights

Emergency physicians can identify critical congenital heart defects in infants using a simplified "pink," "blue," or "gray" categorization based on clinical data. This approach aids in timely stabilization for infants with complex cardiac malformations.

Area of Science:

  • Pediatric Cardiology
  • Emergency Medicine
  • Neonatal Health

Background:

  • Congenital heart disorders (CHDs) are complex and challenging to diagnose in infants due to varied malformations and age-dependent physiology.
  • Early identification and intervention are crucial for improving outcomes in neonates with critical CHDs.
  • Current diagnostic approaches may not always be readily applicable in emergency settings.

Purpose of the Study:

  • To present a simplified clinical approach for emergency physicians to identify infants with critical congenital heart disorders.
  • To categorize critical CHDs into actionable groups for initial management in emergency settings.
  • To facilitate prompt stabilization of infants with undiagnosed critical cardiac lesions.

Main Methods:

  • Compiling data from patient history and physical examination findings.
  • Classifying critical congenital cardiac lesions into ductal-dependent obstructive (left-sided and right-sided) and shunting/mixing categories.
  • Utilizing a simplified "pink," "blue," or "gray" categorization system for clinical assessment.

Main Results:

  • The proposed approach enables emergency providers to categorize infants with critical CHDs based on clinical presentation.
  • "Pink" infants may represent left-sided obstructive lesions, "blue" infants right-sided obstructive lesions, and "gray" infants shunting or mixing lesions.
  • This classification aids in identifying the need for immediate stabilization procedures.

Conclusions:

  • A simplified clinical approach can effectively aid emergency physicians in identifying infants with critical congenital heart disorders.
  • The "pink," "blue," and "gray" categorization provides a practical framework for initial assessment and management.
  • This strategy supports life-saving stabilization efforts for neonates awaiting specialized cardiac care.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
661
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
772
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
732
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
585